The Financial News

The Financial News

This 40-Year-Old MIT Spinoff Is Building the Future of Military and Medical Displays


Kopin CEO Michael Murray explains how this 40-year-old MIT spinoff is building the displays the Pentagon desperately needs — MicroLED technology 100x brighter than OLED that lets warfighters see adversaries before being seen. With a $15.4 million investment from the Secretary of War, a major partnership with NATO’s dominant night vision supplier Theon, and expansion into drones, medical headsets, and automotive, Murray breaks down why Kopin’s transformation plan is just hitting its stride.

Topics covered:
• Kopin’s transformation from component seller to full application-specific solution provider
• Why the Pentagon invested $15.4M in Kopin to build sovereign color MicroLED capability in the U.S.
• The Theon partnership and DarkWAVE attachment for NATO night vision goggles — adding color and thermal imaging
• First-person viewer drone goggles and removing Chinese-made displays from U.S. defense supply chains
• Medical headset partnership with Carl Zeiss for 3D surgical displays
• The bidirectional display breakthrough — NeuralDisplay technology that reads the user’s physical responses
• Revenue growth trajectory: 20-30% CAGR expected, with path to profitability through foundry absorption
• Industrial and automotive market expansion plans for 2026

Michael Murray, CEO of Kopin Corporation, joins Asit Sharma for this interview.

—

This video is brought to you by The Motley Fool. Visit https://fool.com/Invest to get access to this special offer. The Motley Fool Stock Advisor returns are +898% as of 3/23/2026 and measured against the S&P 500 returns of +183% as of 3/23/2026. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary, not all Motley Fool Stock Advisor picks have performed as well.


Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All rights reserved. | The Financial Times